MEDIUM confidence: 100% data completeness, but the composite (57) sits in the indecisive 30–70 range — strong-buy and short calls require a more decisive composite. What does confidence mean?
Technical context for active traders — derived from price, the 50/200-day moving averages, the 52-week range, and recent volume. Not part of the QScore.
AI classification of policy/regulatory sensitivity from the company's sector, industry, and business description. Exposure/sensitivity only — not a political opinion, a prediction of government action, or investment advice. As of 2026-07-10.
Fama-French 5-factor (2×3) + Momentum, monthly OLS with Newey-West errors. Bars show signed factor betas; faded bars/figures aren't statistically significant.
Dated events from the market calendar; the “also watch” items are AI-generated observations from QScoring data. Informational only — not investment advice, and dates can change.
Working the DCF backward: holding the assumptions below, this is the free-cash-flow growth today's price implies over the next 10 years. It is a read on the price's embedded expectations — not a fair-value or target price.
The price implies FCF growth above the analyst consensus of 6.2%/yr (revenue basis).
Base free cash flow $1.8B (avg FY2023–FY2025; latest year $2.0B) · equity value $59.5B · levered FCF discounted at the cost of equity. Reverse DCF is illustrative, not advice.
Net buyback (repurchases less issuance) ÷ market cap, plus trailing dividend yield.
Avg target $113 (last qtr, 5 analysts) → $113 (last mo, 5) (+0.0%).
Buy-rated share 78% → 78% over ~3 months (+0pp).
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Oct 2026 | $1.02 | $1.04 | +2.0% |
| Jul 2026 | $0.98 | $1.07 | +8.7% |
| Apr 2026 | $0.93 | $0.96 | +3.2% |
| Jan 2026 | $0.92 | $0.96 | +4.1% |
| Oct 2025 | $0.85 | $0.88 | +3.3% |
| Jul 2025 | $0.81 | $0.85 | +4.4% |
| Apr 2025 | $0.77 | $0.79 | +2.5% |
| Jan 2025 | $0.74 | $0.76 | +2.7% |
Net insider -$3.6M over 180 days (1 open-market buys, 18 sells). Insider buying is the informative signal; routine selling is normal.
Short interest, days-to-cover, and institutional-ownership change require a data-plan upgrade (not yet available).
Forward-return IC, quintile spread & hit rate publish on /performance as the tracking panel accrues enough no-look-ahead history.
| Metric (USD) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $5.9B— | $6.2B+5.8% | $6.1B-2.6% | $7.4B+22.0% | $8.2B+11.1% |
| EPS (dil.) | $2.35— | $2.26-3.8% | $2.08-8.0% | $1.93-7.2% | $3.09+60.1% |
| Free Cash Flow | $920M— | $1.6B+68.9% | $1.5B-1.0% | $1.7B+12.6% | $2.0B+14.8% |
| Gross Margin | 37.9% | 37.6%-0.4pp | 42.0%+4.4pp | 40.4%-1.6pp | 47.9%+7.5pp |
| Operating Margin | 24.5% | 25.1%+0.6pp | 26.0%+0.9pp | 24.3%-1.7pp | 28.4%+4.1pp |
| Net Margin | 20.2% | 18.1%-2.1pp | 17.5%-0.6pp | 15.1%-2.4pp | 21.8%+6.7pp |
Absolute figures with year-over-year change. Margins show the level with the change in percentage points (pp). “n/m” = not meaningful (prior ≤ 0); ⚠ marks a large percentage off a small base — read the dollar figure.
The QScore of 57 for NDAQ indicates a moderately positive outlook, driven by strong momentum and growth scores, with the stock exhibiting a 24.1% return over the past year and 61.3% EPS growth. The value category scores lower due to the stock trading at a premium, with a P/E of 28.8 and P/B of 5.0. Notably, the short-term score of 63 diverges from the long-term score of 52, suggesting a recent uptick in the stock's performance, with a bullish 50-day versus 200-day moving average crossover.